Medicago was a public biotechnology company based in Quebec City, Canada. The company specialized in plant-based production of vaccines and therapeutic proteins. Utilizing live plant leaves as bioreactors, Medicago developed virus-like particles for rapid vaccine development. In 2013, Medicago was acquired by Mitsubishi Tanabe Pharma for $360M USD.
Vaccine platform
CTI LSF I
Syndicate
n/a
April 4, 2011
Medicago acquired by Mitsubishi Tanabe Pharma for $360M USD
PIPE
Medicago’s plant-based platform had significant speed and cost advantages compared to traditional protein and vaccine production methods
